New real-world data from the 1INSPIRE study shows that frontline niraparib (Zejula) maintenance is well-tolerated in patients ...
Mirvetuximab soravtansine shows 16.4-month OS in ovarian cancer, though poor ECOG status and toxicity significantly impact ...
Because the immune system resides beneath the skin's barrier, the initial cellular mutation caused by UV light occurs before ...
Dr. Don Dizon discusses why early fertility referral and avoiding clinical assumptions are vital for young breast cancer patients at diagnosis. According to Dizon, the discussion regarding fertility ...
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...
Letrozole monotherapy failed to show noninferiority compared to standard chemotherapy followed by letrozole as a first-line ...
Explore how Jessica MacIntyre, ONS President, is transforming oncology care through APP fellowships, a new skin toxicity ...
Basic knowledge of types of intravenous ports can help nurses who manage these for patients. Throughout the course of treatment, many patients with cancer receive chemotherapy, intravenous fluids, ...
The SISTER trial finds 1:1 peer support significantly improves endometrial cancer treatment completion for Black women, per ...
Shachar emphasized that the key takeaway is the need for proactive and consistent toxicity monitoring across all patients ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for TLX101-Px, an investigational PET imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results